SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001085146-22-004264
Filing Date
2022-12-27
Accepted
2022-12-27 11:09:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 MARKEY JOHN vlona1.htm SC 13G/A 25477
  Complete submission text file 0001085146-22-004264.txt   26772
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Subject) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92206 | Film No.: 221487268
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10096 RIDGEWOOD DRIVE TWINSBURG OH 44087
Business Address
Markey John (Filed by) CIK: 0001948530 (see all company filings)

Type: SC 13G/A